Posted by: Audrey Erbes | October 20, 2013

Rating Regional Life Science Clusters Plus Events and Jobs

Luke Timmerman of Xconomy has done a new study on the health of life science clusters and found Boston to be growing with 35 companies and now number one vs. San Francisco with 24 if you base score on having more than $100 million in cash. He admits that there have been many previous stories and studies, some with flawed criteria, all trying to rate the regions.  He makes case for financial fire power to bring a product to market as the principal criterion.

I would question his reliance on BIO membership lists as base source of companies since it focuses on establishment companies and not the “new shoots” and science-based entities. There can be kinds of activity, such as, new companies which make deals to license out their technology early which wouldn’t be considered and companies in incubators like QB3 in Mission Bay with over 65 companies alone which demonstrate the relative vitality of region. Anyway, check out his list in the article.

We know that BIO annual meeting regional sponsors always produce studies about the time of their conference that make their regions appear to be top stars and most often degrade the Bay Area. The definition of San Francisco as 4 different smaller regions is a great ploy to reduce its significance; the number of research hospitals makes New York stronger, etc.

Check out the biotech garages from QB3 (quantitative biosciences at UCSF, UCB and UCSC) and new additional space in San Francisco .

In other news MMM has brought out its latest career and salary survey on the pharmaceutical industry showing differences across marketing and sales functions throughout the industry. Highlights include that number of employees declined by over 8,000, just under that for 2012 decline but salaries were up and job satisfaction was as well. See survey at

The most recent Medtech industry survey for general and corporate staff was published in 2012 in MDDI. You can also find salaries for other functions at the same location.

Median salaries for medtech employees in general and corporate management increased nearly 14% from 2011 to 2012 while those in R& D saw their salaries climb 13.5% compared to the previous year. Typically the MDDI report is published annually in November of each year.

Highlights for the Upcoming Week

  • BioCentury This Week, See new program Webcast Starting Sunday, Oct. 20, 2013, 2013, Available anytime starting at 9:00 a.m. EDT; Topic: “After the Shutdown, Sequestration Lurks;” Speakers: Dr. Howard Garrison, Deputy Executive Director for Policy at the Federation of American Societies for Experimental Biology (FASEB); Kevin Wilson, Director of Public Policy at the American Society for Cell Biology (ASCB); Steven Grossman, Deputy Executive Director at the Alliance for a Stronger FDA plus Dan Mendelson, CEO of Avalere Health.
  • BayBio, Monday Mid-day, Oct. 21, 2013; Topic: “Lunch and Learn: Getting Paid for Innovation: What’s Your Reimbursement Strategy?” Speaker: Alex Bastian, Vice President, GfK Bridgehead
  • Bio2Device Group, Tuesday Morning, Oct. 22, 2013; Topic: “The Right Drug in the Right Place at the Right Time – a Novel Approach for Treating Bacterial Pneumonias;” Speakers: Kevin Corkery, Director of Pharmaceutical Development, Novartis,
  • Northern California BioPharmaceutical Project Management and Silicon Valley Association of Strategic Alliance Professionals Joint Meeting, Tuesday Evening, October 22, 2013; Topic: “Key Value Drivers across the Biopharmaceutical Alliance Lifecycle:Maximizing stage-gate driven value in a tough regulatory and funding environment, from joint R&D ventures to co-commercialization;” Panelists:Titus Plattel, VP of Corporate Development, Bavarian Nordic-ImmunoTherapeutics; Janice Babia-Ramos, Group Product Director, Alliance Management Oncology at Janssen; Lisa Hagerty-McMahon, Principal & Owner Hagerty-McMahon Consulting Chapter President, Northern California BioPharma PM; Moderator: Norma Watenpaugh, Principal Phoenix Consulting Group, Global Board Member, Association of Strategic Alliance Professionals
  • ASQ, Tuesday and Wednesday, Oct. 22-23, 2013; Topic: “Audit Avalanche- ASQ Biomedical Division”
  • ShareVault, Wednesday Morning, Oct. 23, 2013; Topic: “How to Win at the Partnering Game;” Speaker: Linda Pullan, Ph.D.
  • BioScience Forum, Wednesday Evening, Oct. 23, 2013; Title: “Microbiome Science: At the Tipping Point;” Speaker: Mohan S. Lyer, Senior Vice President, Corporate Development, Second Genome, Inc.
  • HBA, Thursday Evening, Oct. 24, 2013; Title:  “Connected Leaders for Connected Health;” Speaker: Carolyn Buck-Luce , Co-Founder and Managing Partner of Imaginal Labs, LLC
  • Bay Bio Invitation for Participation, Oct. 24 – Nov. 2, 2013; Event: Participation with Bay Bio in Bay Area Science Festival
  • BayBio, Thursday Evening, Oct. 24, 2013; Event: “BayBio Life Science Pub Night”
  • HBA, Friday Morning Oct. 25, 2013; Topic: “Digital Fluency: A Key Leadership Trait for the 21st Century;” Speakers: Carolyn Buck Luce (managing partner, Imaginal Labs, LLC) and Meghan Poulsom (digital coach, Educated Change, LLC)
  • GABA, Friday Afternoon, Oct. 25, 2013; Topic: “Clinical Evaluation & Investigation of Medical Devices in Europe;” Panelists:  Juergen Stettin, PROSYSTEM AG, Hamburg, Germany; Oliver P. Christ, Co-founder and CEO, PROSYSTEM USA LLC, San Diego, CA; Lucie Merkle, Executive Director, Bavarian U.S. Offices of Economic Development, LLC, West Coast; Kamel Chaïr, M.D./ Medical Advisor, Postmarket Surveillance, Stryker Neurovascular

Highlights for Business Development Course in December

UC Berkeley Extension Course, Thursday and Friday, Dec. 5-6, 2013; Course: “Life Science Business Development,” (formerly known as Biotechnology Business Development); Lead Instructor: Audrey S. Erbes, Ph.D., Principal, Erbes & Associates and blog; Guest Speakers: Allison Dupuy, Ph.D., Senior Director in the Life Sciences division of Simon-Kucher & Partners; Harold (Hal) Etterman, MBA, CEO, Knight Financial Plans & Services, LLC; Carolyn Feamster, MBA, a business strategy and analysis consultant; Gilbert R. Mintz, Ph.D., President of GRM Associates; Ginger Dreger, J.D., M.S., partner in Arnold & Porter LLP’s intellectual property practice group; Chris Dokomajilar, Director, Business Intelligence, BioCentury; Location: Downtown University of California, Berkeley Extension, 425 Market St., 8th Floor, San Francisco, CA 94105; Cost: Fall term—fee: $895, (440.8-001). Register at

Find all the details for these upcoming events plus those through March 2014 in Audreys Picks Oct. 20, 2013 by right clicking the highlighted title. You can also download the pfd of Jobs That Crossed My Desk Through Oct. 20, 2013. This latter list includes jobs I discovered this past week as well as the previous two weeks.



Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s


%d bloggers like this: